DS, L., FV, G., D, E. M., MR, G., DM, B., JS, H., . . . CG, F. (2020). Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial. Ophthalmology, 127(2), 186. https://doi.org/10.1016/j.ophtha.2019.07.011
Chicago Style (17th ed.) CitationDS, Liao, et al. "Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial." Ophthalmology 127, no. 2 (2020): 186. https://doi.org/10.1016/j.ophtha.2019.07.011.
MLA (9th ed.) CitationDS, Liao, et al. "Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial." Ophthalmology, vol. 127, no. 2, 2020, p. 186, https://doi.org/10.1016/j.ophtha.2019.07.011.